Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Inquiry Reveals Appalling Gaps In Care For Parkinson's
The All Party Parliamentary Group (APPG) for Parkinson"s Disease has released a shocking new report that documents severe inequalities in access to Parkinson"s services in the UK.

DrugScope Welcomes National Treatment Agency Announcment Of Increased Funding For Drug Treatment
DrugScope has welcomed the National Treatment Agency for Substance Misuse"s announcement of an extra ÷£11.8m government investment in drug treatment.
News of the day
Foresight Biotherapeutics Announces Positive Results From An Open Label Pilot Study In Patients With Viral Conjunctivitis
Foresight Biotherapeutics, Inc. announced completion of a multi-center open-label pilot study of FST100 in the treatment of viral conjunctivitis. FST-100 is a novel formulation of dexamethasone that includes povidone iodine. The trial studied patients with clinical signs and symptoms of acute conjunctivitis who tested positive for adenoviral antigen by the RPS Adeno Detector® (RPS). Patients were enrolled in a single arm utilizing FST-100 topical ophthalmic suspension given 4 times daily for 5 days. The RPS Adeno Detector® test was performed at baseline and at each visit along with conjunctival swabs for adenoviral titers by quantitative PCR (qPCR) and cell culture with confirmatory immunoflourescence (CC-IFA). The primary endpoint of the study was clinical resolution of conjunctival injection and conjunctival discharge. These signs were scored on a scale from zero to three. Secondary endpoints included reduction of viral titers measured by qPCR and eradication of infectious virus determined by CC-IFA.
Health Insurance

Increased 'Dialogue' Needed In Black Community About HIV/AIDS, Opinion Piece Says

"HIV/AIDS has literally become a state of emergency in the [b]lack community and our leaders, organizations and institutions can no longer afford to remain silent," Lisa Fager Bediako, project coordinator for the Congressional Black Caucus Foundation"s ACT! Against AIDS Leadership Initiative, writes in the Florida Courier. She continues, "Over the past three years that I have been involved in HIV/AIDS prevention and advocacy, one thing has become apparent: the crucial need for expanded dialogue about HIV/AIDS within the [b]lack community." Bediako writes, "In order to reach a larger audience, we need to have hard conversations, creative outreach and committed support from leadership organizations and media outlets," concluding, "We cannot afford to ebb and flow our conversations of HIV/AIDS while this preventable disease continues to devastate our community" (Bediako, 7/10). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009